AMGEN ONCOLOGY

SEE LIFE BREAK THROUGH™

KRASG12C

Despite 40 years of research, KRAS remains an elusive target—has science found a way to target this common oncogenic protein?

LEARN MORE

BiTE®

IMMUNO-ONCOLOGY PLATFORM

DESIGNED TO CLOSE THE SPACE BETWEEN
T CELLS AND TUMORS

A Broad and
Diverse Pipeline

Learn More

Science

From innovative modalities to unique pathways, see how we’re advancing oncology treatment

PIPELINE

Explore our investigational agents and clinical trials across a range of solid tumors and hematologic malignancies

Resources

View and download a wealth of educational resources for personal use